Publications & Presentations

 

DENS Publications

Carise, D., & Gurel, O.  (2003).  Benefits of integrating assessment technology with treatment: The DENS project.  In J. L. Sorensen, R. Rawson, J. Guydish, & J.E. Zweben (Eds.), Drug Abuse Treatment Through Collaboration: Practice and Research Partnerships that Work.  APA. 

McLellan, A.T., Carise, D., and Kleber, H.D. (2003, In Press). Can the national addiction treatment infrastructure support the public’s demand for quality care? Journal of Substance Abuse Treatment. 

Carise, D., Gurel, O., McLellan, A.T., & Kendig, C.  (2003 In Submission).  Giving clinical meaning to patient assessment: technology transfer to improve treatment care planning and services.  Drug and Alcohol Dependence.

Gurel, O., Carise, D., Kendig, C, & A. Thomas McLellan (2002 In Submission). Development and use of an electronic resource guide for referral to social and health services.   Drug and Alcohol Dependence 

Carise, D., Cornely, W., & Gurel, O. (2002).  A successful researcher-practitioner collaboration in substance abuse treatment.  Journal of Substance Abuse Treatment, 23 (2), 157-162. 

Carise, D., McLellan, A.T., Cacciola, J., Love, M., Cook, T., Bovasso, G., & Lam, V. (2001).  Suggested specifications for a standardized Addiction Severity Index database.  Journal of Substance Abuse Treatment,. 20 (3), 239-244.

Carise, D., McLellan, A.T., Gifford, L., & Kleber, H.D.  (2000).  Development of a "treatment program" descriptor – the Addiction Treatment Inventory. Substance Use and Misuse, 35 (12-14), 1797-1818. 

Carise, D., McLellan, A.T., Gifford, L., & Kleber, H.D. (1999). Developing a national addiction treatment information system.  An introduction to DENS: the Drug Evaluation Network System.  Journal of Substance Abuse Treatment, 17 (1-2), 67-77.

Crevecoeur, D., Finnerty, B., & Rawson, R.A. (2000).  Los Angeles County Evaluation System    (LACES): bringing accountability to alcohol and drug abuse treatment through a collaboration between providers, payers, and researchers. Journal of Drug Issues, 32, 865-880.